Health · 41 views
Algorithmic tool may improve screening of patients for an Alzheimer's clinical trial
A new blood-based screening algorithm dramatically reduced the number of unnecessary PET scans needed to recruit patients at risk of Alzheimer's disease for a clinical trial, according to research from scientists at the Keck School of…
Summary
A new blood-based screening algorithm dramatically reduced the number of unnecessary PET scans needed to recruit patients at risk of Alzheimer's disease for a clinical trial, according to research from scientists at the Keck School of Medicine of USC published in the journal Alzheimer's & Dementia . Known as AHEAD 3-45, the clinical trial is a phase 3 international study testing whether earlier treatment with an approved Alzheimer's drug, lecanemab, could lead to better outcomes.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- New microscopy platform enables imaging of neuronal activity at single-cell resolution at unprecedented tissue depthContinue reading
- Lab-on-a-chip predicts which cancer treatments may work for pediatric acute lymphoblastic leukemiaContinue reading
- Nearly 75% of ex-NFL players who died from 2008-2023 had CTE, study findsContinue reading
- Another Win for Novel Drug, This Time in EGFR-Mutated Lung CancerContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow